Search

Bridget OConnell-Long

Bridget OConnell-Long

March 12, 2020

Bridget O'Connell-Long, pediatric resident at OHSU Doernbecher Children's Hospital.(OHSU)

BRILLIANCE trial

BRILLIANCE trial

March 04, 2020

Staff at Oregon Health & Science University's Casey Eye Institute perform the first-ever in vivo CRISPR gene edit procedure for the BRILLIANCE clinical trial. The study uses the gene-editing technology CRISPR to repair mutations in the CEP290 gene that cause a rare form of inherited blindness called Leber congenital amaurosis type 10. The trial is sponsored by Allergan plc. and Editas Medicine. (OHSU/Kristyna Wentz-Graff)

See More Stories